clarithromycin has been researched along with Diffuse Mixed Small and Large Cell Lymphoma in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Cho, SJ; Choi, J; Chung, H; Chung, SJ; Kim, JL; Kim, SG; Lee, A | 1 |
| Cañas-Hernandez, F; de Miguel-Martinez, I; Lorenzo-Garde, L | 1 |
| Tu, S; Yang, H | 1 |
| Bilgilier, C; Dolak, W; Kiesewetter, B; Makristathis, A; Raderer, M; Simonitsch-Klupp, I; Steininger, C | 1 |
| Katelaris, P; Mitchell, H | 1 |
| Ajioka, Y; Fujino, MA; Maruta, K; Nishikura, K; Watanabe, H; Yamashita, H | 1 |
| Delchier, JC; Lamarque, D; Lascols, C; Soussy, CJ; Tankovic, J | 1 |
| Alpen, B; Neubauer, A; Röbbecke, J; Stolte, M; Wündisch, T | 1 |
1 review(s) available for clarithromycin and Diffuse Mixed Small and Large Cell Lymphoma
| Article | Year |
|---|---|
Epidemiology, clinical impacts and current clinical management of Helicobacter pylori infection.
Topics: Amoxicillin; Anti-Bacterial Agents; Australia; Breath Tests; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, Non-Hodgkin; New Zealand; Peptic Ulcer; Proton Pump Inhibitors; Risk Factors; Stomach Neoplasms; Treatment Outcome | 2016 |
2 trial(s) available for clarithromycin and Diffuse Mixed Small and Large Cell Lymphoma
| Article | Year |
|---|---|
Empiric Versus Clarithromycin Resistance-Guided Therapy for Helicobacter pylori Based on Polymerase Chain Reaction Results in Patients With Gastric Neoplasms or Gastric Mucosa-Associated Lymphoid Tissue Lymphoma: A Randomized Controlled Trial.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Biopsy; Bismuth; Clarithromycin; DNA, Bacterial; Drug Resistance, Bacterial; Drug Therapy, Combination; Esomeprazole; Female; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, Non-Hodgkin; Male; Metronidazole; Middle Aged; Polymerase Chain Reaction; Prospective Studies; Republic of Korea; RNA, Ribosomal, 23S; Stomach Neoplasms; Tetracycline; Treatment Outcome | 2020 |
Helicobacter pylori eradication therapy in gastric high grade non Hodgkin's lymphoma (NHL).
Topics: Aged; Anti-Ulcer Agents; Clarithromycin; Combined Modality Therapy; Drug Therapy, Combination; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Non-Hodgkin; Metronidazole; Omeprazole; Prospective Studies; Remission Induction; Stomach Neoplasms; Treatment Outcome | 2001 |
5 other study(ies) available for clarithromycin and Diffuse Mixed Small and Large Cell Lymphoma
| Article | Year |
|---|---|
[Bacteriemia due to Mycobacterium canariasense in an oncohematological patient with a long-term central device].
Topics: Aged; Bacteremia; Bacterial Typing Techniques; Catheter-Related Infections; Catheterization, Central Venous; Ciprofloxacin; Clarithromycin; Humans; Lymphoma, Non-Hodgkin; Male; Mycobacterium; Mycobacterium Infections | 2014 |
[Progress in the treatment of Helicobacter pylori infection].
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Drugs, Chinese Herbal; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, Non-Hodgkin; Metronidazole; Peptic Ulcer; Probiotics; Stomach Neoplasms | 2014 |
Prevalence of clarithromycin-resistant Helicobacter pylori strains in gastric mucosa-associated lymphoid tissue lymphoma patients.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prevalence; Retrospective Studies; Stomach Neoplasms | 2016 |
When can complete regression of low-grade gastric lymphoma of mucosa-associated lymphoid tissue be predicted after helicobacter pylori eradication?
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Biopsy; Clarithromycin; Female; Follow-Up Studies; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Non-Hodgkin; Male; Middle Aged; Proton Pump Inhibitors; Remission Induction; Stomach; Stomach Neoplasms; Time Factors | 2000 |
Clarithromycin resistance of Helicobacter pylori has a major impact on the efficacy of the omeprazole-amoxicillin-clarithromycin therapy.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Biopsy; Clarithromycin; DNA, Bacterial; Drug Resistance; Drug Resistance, Multiple; Drug Therapy, Combination; Dyspepsia; Enzyme Inhibitors; Female; Gastric Fundus; Gastric Mucosa; Gastritis; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Non-Hodgkin; Male; Metronidazole; Middle Aged; Omeprazole; Peptic Ulcer; Pyloric Antrum; Retrospective Studies; Stomach Neoplasms; Treatment Outcome | 2001 |